Chole Timothy 4/A

4/A · ROCKWELL MEDICAL, INC. · Filed Apr 17, 2026

AI-generated summary of this filing

Updated Apr 17, 2026

Rockwell Medical (RMTI) SVP/CCO Chole Timothy Receives Award

What Happened

Chole Timothy, Senior Vice President and Chief Commercial Officer of Rockwell Medical, was granted 85,000 performance-based restricted stock units (PSUs) on 2025-05-20. The grant is reported as an award/derivative transaction (code A) at $0.00 per share (no cash paid at grant).
These PSUs do not convert into actual shares unless performance and time-based conditions are met; they are not an open-market purchase or sale.

Key Details

Transaction date: 2025-05-20; reported in an amended Form 4 filed 2026-04-17 (this award was inadvertently omitted from the original Form 4).
Grant: 85,000 PSUs; reported price: $0.00 (award/derivative).
Performance terms (footnote): three-year performance period and term; vesting may occur on or after the first anniversary only if the average closing price over any 60 consecutive trading days during the three-year period equals two times the base price. Base price = $2.14, so the hurdle = $4.28.
Shares owned after the transaction: not specified in this filing.
Timeliness: This is an amended filing correcting an omission (late reporting).

Context

These are contingent equity awards (PSUs). They represent potential future insider ownership only if the stock-price hurdle and time-based vesting conditions are satisfied; they do not indicate an immediate purchase or sale.
Because the filing is amended to include a previously omitted award, the amendment corrects the record but does not by itself imply any trading intent.

Form 4/AAmended

Period: 2025-05-20

SVP and CCO

Transactions

Award
Performance-based restricted stock units
[F1]
2025-05-20+85,000→ 85,000 total
Exp: 2028-05-20→ Common Stock (85,000 underlying)

Footnotes (1)

[F1]These are performance-based restricted stock units ("PSU") with terms as follows. The term of each PSU award runs from the grant date through the third anniversary of the grant date. Any unvested PSUs remaining after the third anniversary will be cancelled. The performance period for the award is the same three-year period. PSUs will vest on or after the first anniversary of the grant date only if the stock price meets the performance hurdle. The performance hurdle is met if the average closing price of the Company's common stock over any 60 consecutive trading days during the performance period equals two times the base price. The base price was calculated as the average closing price over the ten trading days ending on the trading day prior to the grant date and is $2.14 for this award.

Signature

/s/ Megan Timmins, Attorney-in-Fact for Timothy Chole|2026-04-17

1 file